Search the Newsreel

DUKE Robotics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Duke Robotics Expands Grid Drone Work, Completes ~$9.2M Offering

Duke Robotics Reports Second Quarter 2026 Financial Results and Provides Business Update

Duke Robotics Corp Expanded 2026 Israel Electric Corporation IC Drone Grid-Maintenance Season Commenced; Purchase Order on Track to Generate the Expected More Than $1 Million in Revenue During 2026 New Bird of Prey Order Received Through Elbit Systems, with Deliveries Expected During 2026 Successfully …

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT falsely claimed consistent handpiece unit sales …

Robotphoenix Schedules Board Meeting to Approve 2026 Interim Results

Microbot Medical earnings beat, revenue fell short of estimates

What Is Uber (UBER) Telling Investors With Its Freight Cyber Probe And Robotics Exit?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Uber Technologies (NYSE:UBER) reported that its Uber Freight unit is investigating a cyber security …

Arbe Robotics (NASDAQ: ARBE) seeks reverse share split to address Nasdaq bid deficiency

Arbe Robotics (NASDAQ: ARBE) is calling a virtual annual general meeting on September 2, 2026, to vote on several key proposals, including a potential reverse share split. This action is in response to a Nasdaq notice issued on April 13, 2026, indicating that Arbe's …

PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.8% - What's Next?

PROCEPT BioRobotics (NASDAQ:PRCT) shares fell 4.8% after reporting mixed Q2 2026 results with revenue growth but a larger-than-expected loss and continued unprofitability. The company faces a class-action lawsuit regarding alleged misleading statements about demand and inventory, adding to investor uncertainty. Despite a CEO stock …

Ubtech Robotics Faces a Pivotal Late-August Stretch as Shareholders Weigh Capital Moves

Serve Robotics (SERV) Is Down 13.9% After Slashing 2026 Guidance And Resetting Its Uber Roadmap

Serve Robotics (SERV) saw its stock drop by 13.9% after reporting second-quarter 2026 sales of US$3.24 million, a widened net loss of US$64.13 million, and significantly cutting its full-year 2026 revenue guidance to US$9-10 million from US$26 million. The company is also re-evaluating its …

Microbot Medical Q2 revenue jumps 100% QoQ

Microbot Medical Inc. announced a 100% quarter-over-quarter revenue and customer growth for Q2 2026, driven by the successful Full Market Release of its LIBERTY System. The company expanded its market presence in the U.S., secured a federal healthcare agreement, and achieved international marketing clearance …

Microbot Medical Inc (MBOT) Earnings Forecast: Future EPS & Revenue Growth Estimates

BERKLEY W R CORP Exits AMC Robotics Corp (AMCI) Position in Sold Out Transaction

BERKLEY W R CORP has fully divested its stake in AMC Robotics Corp (AMCI) as of June 30, 2026, selling all shares at $4.98 each. This exit aligns with BERKLEY W R CORP's value-oriented investment strategy, which favors stable, income-generating assets over speculative growth, …

PRCT Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT made materially false and misleading statements …

Arbe Robotics Expands AI Radar Push as It Targets Defense, Drones and Robotaxis

Arbe Robotics is expanding the application of its ultra-high-resolution radar technology beyond the automotive sector to target defense, security, drones, and marine markets. The company, which produces radar semiconductor chipsets, is now manufacturing complete radar units for non-automotive uses due to slower-than-expected automotive adoption …

Uber Blindsides Serve Robotics With Surprise Stake Sale

Uber has unexpectedly sold its entire stake in Serve Robotics without prior notice to the company, signaling a significant strategic divergence in their approach to autonomous delivery. This move reflects Uber's shift towards larger autonomous vehicles and robotaxis, moving away from sidewalk delivery robots. …

PROCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that Procept misled investors by failing to disclose …

ARBE: Radar commercialization accelerates, targeting breakeven by 2028 and major deployments by 2029

Arbe Robotics (ARBE) is accelerating the commercialization of its ultra-high-resolution radar technology, which is used in automotive, defense, and civilian sectors. The company is targeting revenue growth, with a goal to achieve breakeven by 2028. Major deployments are anticipated in China and the U.S. …

Uber surprised robotics company Serve by selling its entire stake

Uber has divested its entire stake in Serve Robotics, an autonomous delivery robot company that originated from Uber's acquisition of Postmates. This move came as a surprise to Serve Robotics, which learned of the selloff through a regulatory filing. The divestiture follows differing views …

Ubtech Robotics (SEHK:9880) Is Getting Fresh Attention, What Is The Market Watching?

Microbot Medical Inc. Q2 2026: Revenue $241K, Net loss $5.63M — 10-Q Summary

Microbot Medical Inc. reported its Q2 2026 results, announcing its first commercial revenue of $241,000, a significant increase from zero in the previous year. Despite this, the company posted a net loss of $5.63 million, worsening from a $3.5 million loss in the prior-year …

Microbot Medical Q2 Results: Sales miss by 29%, EPS in line

Microbot Medical (NASDAQ: MBOT) reported Q2 EPS of $(0.08), meeting analyst estimates and showing a 20% improvement year-over-year. However, the company's sales of $241,000 significantly missed the estimated $340,000 by 29.12%, raising concerns about its top-line growth despite improved per-share losses. This discrepancy suggests …

Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT artificially inflated its reported U.S. handpiece …

UBTECH Robotics Calls 2026 Extraordinary Meeting to Approve Financing and H-Share Incentive Plan

Microbot Medical (NASDAQ:MBOT) Issues Earnings Results

Microbot Medical (NASDAQ:MBOT) announced its earnings results, reporting a quarterly loss of $0.08 per share, which met analyst expectations, but revenue of $0.24 million fell short of the $0.33 million consensus. Following the announcement, shares declined 13.4% to $1.68, nearing the company's one-year low. …

Microbot Medical partners with Lovell Government Services to target federal healthcare systems

Microbot Medical has partnered with Lovell Government Services to expand its reach into federal healthcare systems, gaining access to over 2,000 facilities for its LIBERTY endovascular robotic system. Concurrently, Microbot signed an agreement with Sanmina to establish a second manufacturing site, anticipating increased demand. …

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

Microbot Medical Inc. (MBOT) reported a Q2 loss of $0.08 per share, in line with the Zacks Consensus Estimate, but missed revenue expectations with $0.24 million against an anticipated $0.31 million. Despite underperforming the market year-to-date, the company holds a Zacks Rank #2 (Buy), …

Lost Money on PROCEPT BioRobotics Corporation (PRCT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

The Gross Law Firm has issued a notice to shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to join a class action lawsuit. The suit alleges that PROCEPT BioRobotics Corporation made false or misleading statements regarding an undisclosed discount program that inflated sales and revenue, …

Microbot Medical (NASDAQ: MBOT) posts first LIBERTY sales with $67M in cash

Microbot Medical (NASDAQ: MBOT) has reported its first commercial revenue from the LIBERTY® Endovascular Robotic System, totaling $241,000 in Q2 2026 and $346,000 for the first half of 2026. Despite these initial sales, the company incurred a net loss of $5.6 million for the …

Microbot Medical's LIBERTY System Gets Marketing Clearance in Israel

Microbot Medical (NASDAQ: MBOT) reported over 100% revenue and customer growth in Q2 2026, driven by the successful Full Market Release of its LIBERTY endovascular robotic system. The company expanded its U.S. sales territories, partnered for access to federal healthcare facilities, and received marketing …

GMEX Robotics Unveils Mount Cutting Robot Sensor Downtime by Up to 90%

PRCT Investor Announcement: PROCEPT BioRobotics Sued on behalf of Investors to Recover Losses after Artificially Inflated Revenue Leads to 18% Stock Drop

Microbot Medical (MBOT) Earnings Date and Reports 2026

Microbot Medical Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

Microbot Medical has filed its 10-Q report, indicating significant revenue and customer growth during the second quarter of 2026. This suggests positive financial performance for the company in the recent period.

Why PROCEPT BioRobotics (PRCT) Is Up 9.6% After Reaffirming 2026 Revenue Guidance Despite Wider Losses

PROCEPT BioRobotics (PRCT) saw its stock rise 9.6% despite reporting wider net losses in Q2 2026, driven by reaffirming its full-year 2026 revenue guidance of US$390 million to US$410 million. The company's investment narrative centers on Aquablation adoption and the path to sustainable profitability, …